Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.

Molecular biology reports - 1 Jun 2020

Minucci Angelo, Scambia Giovanni, Santonocito Concetta, Concolino Paola, Urbani Andrea

Abstract excerpt

The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Betacoronavirus
Share to Clinical Laboratory Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronavirus Infections

Share to COVID-19 Testing

Share to Early Diagnosis

Share to Pandemics

Share to Pneumonia, Viral

Share to Referral and Consultation

Source

Open in PubMed Open full text

Identifiers

PMID: 32388698
DOI: 10.1007/s11033-020-05479-3
PMCID: PMC7210797

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.PMID 32388698Read ↗

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.Semantic proximity Read ↗

Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals.Semantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in SingaporeSemantic proximity Read ↗

Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review.Semantic proximity Read ↗

Europe does it better: molecular testing across a national health care system-the French example.Semantic proximity Read ↗

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY StudySemantic proximity Read ↗

Transition to telephone genetic counseling services during the COVID‐19 pandemicSemantic proximity Read ↗

Learning Healthcare System for the Prescription of Genetic Testing in the Gynecological Cancer Risk.Semantic proximity Read ↗

BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.